Firm Tied to Trump's Sons Won $40 Million in Federal Disease-Screening Contracts
· Investigations · United States
A company linked to President Donald Trump's sons received nearly $40 million in federal contracts to screen for Ebola and other infectious diseases, ProPublica reported. The contracts cover health screening work at points of entry, a function that expanded during outbreaks of diseases such as Ebola. ProPublica's investigation raises questions about how the firm obtained the work and about the overlap between the Trump family's business interests and federal contracting. The report does not detail the terms of the individual contracts or how the money was spent. It adds to scrutiny of federal spending and conflict-of-interest questions involving companies connected to the president's family.
Why it matters:Public procurement tied to politically connected firms is a core accountability issue, and the scale of these contracts will draw scrutiny of conflict-of-interest rules in federal spending.
Key points
- Contracts total nearly $40 million for Ebola and other disease screening
- The company is linked to Trump's sons, per ProPublica
- The work involves screening at points of entry
Sources (original reporting)
More stories from this day
- State Lawyers Allowed to Ghost Clients for Years, ProPublica Finds
- Eleven-Day-Old Baby's ER Care Questioned Over Delayed Vitamin Shot
- FBI probes Nvidia CEO Jensen Huang's affair with alleged Chinese spy
- Nvidia shares sink as board probes alleged spy link to CEO's affair
- Lahaina wildfire survivors face lasting health and recovery struggles
- Bayer wins FDA approval for first Factor XIa blood thinner